BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38505849)

  • 1. ZX703: A Small-Molecule Degrader of GPX4 Inducing Ferroptosis in Human Cancer Cells.
    Hu M; Li X; Wang L; Zhang Y; Sun Y; Hua H; Liu H; Cai T; Zhu D; Xiang Q
    ACS Med Chem Lett; 2024 Mar; 15(3):406-412. PubMed ID: 38505849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders.
    Li X; Hu M; Zhang Y; Hua H; Sun Y; Xiang Q; Zhu D
    Bioorg Chem; 2024 Mar; 144():107115. PubMed ID: 38232684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
    Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
    Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent GPX4 degrader to induce ferroptosis in HT1080 cells.
    Song H; Liang J; Guo Y; Liu Y; Sa K; Yan G; Xu W; Xu W; Chen L; Li H
    Eur J Med Chem; 2024 Feb; 265():116110. PubMed ID: 38194774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect.
    Wang C; Zheng C; Wang H; Shui S; Jin H; Liu G; Xu F; Liu Z; Zhang L; Sun D; Xu P
    Eur J Med Chem; 2023 Feb; 247():115072. PubMed ID: 36603510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.
    Cai M; Ma F; Hu C; Li H; Cao F; Li Y; Dong J; Qin JJ
    Bioorg Med Chem; 2023 Jul; 90():117352. PubMed ID: 37257255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4.
    Zhu L; Hu S; Yan X; Zeng Q; Zhang B; Jiang L; Yao SQ; Ge J
    Bioorg Chem; 2023 May; 134():106461. PubMed ID: 36924654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo.
    Luo T; Zheng Q; Shao L; Ma T; Mao L; Wang M
    Angew Chem Int Ed Engl; 2022 Sep; 61(39):e202206277. PubMed ID: 35924720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4.
    Zhang W; Jiang B; Liu Y; Xu L; Wan M
    Free Radic Biol Med; 2022 Feb; 180():75-84. PubMed ID: 35038550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
    Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
    Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
    Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
    Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
    Forcina GC; Dixon SJ
    Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer.
    Sui X; Zhang R; Liu S; Duan T; Zhai L; Zhang M; Han X; Xiang Y; Huang X; Lin H; Xie T
    Front Pharmacol; 2018; 9():1371. PubMed ID: 30524291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
    Li D; Zhang M; Chao H
    Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferroptosis: An emerging therapeutic opportunity for cancer.
    Wang L; Chen X; Yan C
    Genes Dis; 2022 Mar; 9(2):334-346. PubMed ID: 35224150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis.
    Rochette L; Dogon G; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization.
    Zheng C; Wang C; Sun D; Wang H; Li B; Liu G; Liu Z; Zhang L; Xu P
    Eur J Med Chem; 2023 Jul; 255():115393. PubMed ID: 37098297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels.
    Han D; Jiang L; Gu X; Huang S; Pang J; Wu Y; Yin J; Wang J
    J Cell Physiol; 2020 Nov; 235(11):8839-8851. PubMed ID: 32329068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.